Innovent Biologics and Daiichi Sankyo have entere
Author: Michael
Sana Biotechnology reported second quarter 2026 f
Coya Therapeutics provided second quarter 2026 fi
Neuro Force One appeared at the 2026 Texas High S
MHRA authorize Lilly’s orforglipron tablet for
Ten teams receive $1m awards as the $101m compet
XPRIZE Healthspan Executive Director Jamie Justi
Backed by a $75m raise, Infinimmune targets cyto
AstronauTx has exercised its option under the com
Remedium Bio has completed the initial close of a